# Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects

> **NCT01364675** · NA · UNKNOWN · sponsor: **Ramathibodi Hospital** · enrollment: 8900 (estimated)

## Conditions studied

- Pre-diabetes
- Pre-hypertension

## Interventions

- **DRUG:** Metformin+Enalapril+Simvastatin
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT01364675
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2016-07
- **Final completion:** 2016-12
- **Target enrollment:** 8900 (ESTIMATED)
- **Last updated:** 2011-06-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01364675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01364675, "Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01364675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*